EMA-话题@MedSci

#EMA#

580篇内容 | 2482人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317594, encodeId=a019131e594d1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Pediatr Hematol Oncol：小儿肿瘤患者侵袭性真菌感染的诊断方法, objectType=article, longId=201668, objectId=f41a201668f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f41a201668f7, replyNumber=0, likeNumber=67, createdTime=2020-10-06, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f41a201668f7, moduleTitle=J Pediatr Hematol Oncol：小儿肿瘤患者侵袭性真菌感染的诊断方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f41a201668f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317593, encodeId=4867131e5938e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效, objectType=article, longId=201580, objectId=a894201580eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a894201580eb, replyNumber=0, likeNumber=55, createdTime=2020-10-05, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a894201580eb, moduleTitle=Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a894201580eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317592, encodeId=382d131e59224, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haematol：维布妥昔单抗联合纳武利尤单抗治疗霍奇金淋巴瘤老年患者的疗效, objectType=article, longId=201575, objectId=f0ab2015e5bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0ab2015e5bd, replyNumber=0, likeNumber=64, createdTime=2020-10-05, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0ab2015e5bd, moduleTitle=Lancet haematol：维布妥昔单抗联合纳武利尤单抗治疗霍奇金淋巴瘤老年患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0ab2015e5bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317591, encodeId=3b86131e5913f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Hematology：去诺舒单抗或可用于治疗骨质疏松症患者的骨质丧失, objectType=article, longId=201460, objectId=9d262014602f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d262014602f, replyNumber=0, likeNumber=71, createdTime=2020-10-03, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d262014602f, moduleTitle=Hematology：去诺舒单抗或可用于治疗骨质疏松症患者的骨质丧失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d262014602f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317590, encodeId=ff62131e59056, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=FDA和EMA已接受bimekizumab治疗银屑病的市场营销申请, objectType=article, longId=201331, objectId=04f220133102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04f220133102, replyNumber=0, likeNumber=75, createdTime=2020-09-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04f220133102, moduleTitle=FDA和EMA已接受bimekizumab治疗银屑病的市场营销申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04f220133102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317589, encodeId=b37c131e589e3, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=闪耀ESMO！礼来阿贝西利(abemaciclib)显著降低HR+，HER2-高危早期乳腺癌患者复发风险达25%, objectType=article, longId=201086, objectId=83de20108654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83de20108654, replyNumber=0, likeNumber=70, createdTime=2020-09-24, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83de20108654, moduleTitle=闪耀ESMO！礼来阿贝西利(abemaciclib)显著降低HR+，HER2-高危早期乳腺癌患者复发风险达25%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83de20108654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317588, encodeId=7edb131e5886d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Clin Oncol：Abemaciclib联合内分泌疗法治疗HR+HER2-淋巴结阳性高风险乳腺癌, objectType=article, longId=201057, objectId=ce9520105e86, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce9520105e86, replyNumber=0, likeNumber=54, createdTime=2020-09-24, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce9520105e86, moduleTitle=J Clin Oncol：Abemaciclib联合内分泌疗法治疗HR+HER2-淋巴结阳性高风险乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce9520105e86)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317587, encodeId=45a4131e587ab, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效, objectType=article, longId=200385, objectId=776020038565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=776020038565, replyNumber=0, likeNumber=59, createdTime=2020-09-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=776020038565, moduleTitle=Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=776020038565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317586, encodeId=e883131e58610, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=FDA和EMA批准OPT-302治疗湿性AMD的III期临床试验, objectType=article, longId=199865, objectId=756f199865ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=756f199865ac, replyNumber=0, likeNumber=90, createdTime=2020-08-25, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=756f199865ac, moduleTitle=FDA和EMA批准OPT-302治疗湿性AMD的III期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=756f199865ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317585, encodeId=98ca131e585e2, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haematol：感染COVID-19的血液恶性肿瘤患者的临床特征和不良预后相关因素, objectType=article, longId=199489, objectId=05571994897d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05571994897d, replyNumber=0, likeNumber=67, createdTime=2020-08-16, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05571994897d, moduleTitle=Lancet haematol：感染COVID-19的血液恶性肿瘤患者的临床特征和不良预后相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05571994897d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317584, encodeId=69ed131e5843e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=晚期神经内分泌肿瘤的治疗或迎新进展！和记黄埔已向EMA提交Surufatinib的营销授权申请, objectType=article, longId=199177, objectId=3bc11991e7f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bc11991e7f6, replyNumber=0, likeNumber=45, createdTime=2020-08-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bc11991e7f6, moduleTitle=晚期神经内分泌肿瘤的治疗或迎新进展！和记黄埔已向EMA提交Surufatinib的营销授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bc11991e7f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317583, encodeId=a541131e583f0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：Avadomide联合obinutuzumab治疗复发性或难治性非霍奇金淋巴瘤, objectType=article, longId=198711, objectId=97c8198e11f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c8198e11f4, replyNumber=0, likeNumber=57, createdTime=2020-08-06, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c8198e11f4, moduleTitle=Lancet Haematol：Avadomide联合obinutuzumab治疗复发性或难治性非霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97c8198e11f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317582, encodeId=497f131e58280, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=基因疗法beremagene geperpavec治疗营养不良性大疱性表皮松解症：即将开展III期临床, objectType=article, longId=198352, objectId=6b7c198352b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b7c198352b0, replyNumber=0, likeNumber=68, createdTime=2020-07-31, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b7c198352b0, moduleTitle=基因疗法beremagene geperpavec治疗营养不良性大疱性表皮松解症：即将开展III期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b7c198352b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317581, encodeId=0a47131e58136, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：暨大学者发现新的小分子RNA在急性髓系白血病中的重要调控作用, objectType=article, longId=198143, objectId=23ff1981439f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23ff1981439f, replyNumber=0, likeNumber=62, createdTime=2020-07-29, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23ff1981439f, moduleTitle=J Hematol Oncol：暨大学者发现新的小分子RNA在急性髓系白血病中的重要调控作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23ff1981439f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317580, encodeId=37a3131e580bd, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：米卡芬素对非亲缘关系脐带血移植受者的疗效和安全性评价, objectType=article, longId=198105, objectId=f0bd19810522, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0bd19810522, replyNumber=0, likeNumber=65, createdTime=2020-07-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0bd19810522, moduleTitle=Ann Hematol：米卡芬素对非亲缘关系脐带血移植受者的疗效和安全性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0bd19810522)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317579, encodeId=a6a8131e57959, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Int J Lab Hematol：血清铁蛋白水平在嗜血细胞淋巴组织细胞病诊断中的意义, objectType=article, longId=198101, objectId=8750198101d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8750198101d2, replyNumber=0, likeNumber=83, createdTime=2020-07-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8750198101d2, moduleTitle=Int J Lab Hematol：血清铁蛋白水平在嗜血细胞淋巴组织细胞病诊断中的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8750198101d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317578, encodeId=8580131e57855, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：TAFRO综合征是特发性多中心Castleman病的一个亚型吗, objectType=article, longId=198088, objectId=3bce19808810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bce19808810, replyNumber=0, likeNumber=88, createdTime=2020-07-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bce19808810, moduleTitle=Am J Hematol：TAFRO综合征是特发性多中心Castleman病的一个亚型吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bce19808810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317577, encodeId=7694131e5778f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=SLS-005（海藻糖）治疗Sanfilippo综合征：EMA持积极意见, objectType=article, longId=197912, objectId=fc6519e9120b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc6519e9120b, replyNumber=0, likeNumber=75, createdTime=2020-07-24, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc6519e9120b, moduleTitle=SLS-005（海藻糖）治疗Sanfilippo综合征：EMA持积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc6519e9120b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317576, encodeId=e99f131e5767e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：动态监测血液和凝血参数可更准确便捷评估COVID-19患者病情和预后, objectType=article, longId=197464, objectId=d1d819e4644b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d819e4644b, replyNumber=0, likeNumber=63, createdTime=2020-07-15, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d819e4644b, moduleTitle=Lancet Haematol：动态监测血液和凝血参数可更准确便捷评估COVID-19患者病情和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1d819e4644b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317575, encodeId=be42131e5754a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：内皮病变、凝血病与新冠肺炎患者预后, objectType=article, longId=196894, objectId=fd551968949e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd551968949e, replyNumber=0, likeNumber=63, createdTime=2020-07-03, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd551968949e, moduleTitle=Lancet Haematol：内皮病变、凝血病与新冠肺炎患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd551968949e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

智智灵药 (审核中...)

前往app查看评论内容

#EMA#

J Pediatr Hematol Oncol：小儿肿瘤患者侵袭性真菌感染的诊断方法

2020-10-06

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效

2020-10-05

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haematol：维布妥昔单抗联合纳武利尤单抗治疗霍奇金淋巴瘤老年患者的疗效

2020-10-05

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Hematology：去诺舒单抗或可用于治疗骨质疏松症患者的骨质丧失

2020-10-03

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

FDA和EMA已接受bimekizumab治疗银屑病的市场营销申请

2020-09-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

闪耀ESMO！礼来阿贝西利(abemaciclib)显著降低HR+，HER2-高危早期乳腺癌患者复发风险达25%

2020-09-24

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Clin Oncol：Abemaciclib联合内分泌疗法治疗HR+HER2-淋巴结阳性高风险乳腺癌

2020-09-24

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：Venetoclax联合地西他滨10日疗法治疗各种AML亚型的疗效

2020-09-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

FDA和EMA批准OPT-302治疗湿性AMD的III期临床试验

2020-08-25

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haematol：感染COVID-19的血液恶性肿瘤患者的临床特征和不良预后相关因素

2020-08-16

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

晚期神经内分泌肿瘤的治疗或迎新进展！和记黄埔已向EMA提交Surufatinib的营销授权申请

2020-08-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：Avadomide联合obinutuzumab治疗复发性或难治性非霍奇金淋巴瘤

2020-08-06

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

基因疗法beremagene geperpavec治疗营养不良性大疱性表皮松解症：即将开展III期临床

2020-07-31

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：暨大学者发现新的小分子RNA在急性髓系白血病中的重要调控作用

2020-07-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：米卡芬素对非亲缘关系脐带血移植受者的疗效和安全性评价

2020-07-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Int J Lab Hematol：血清铁蛋白水平在嗜血细胞淋巴组织细胞病诊断中的意义

2020-07-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：TAFRO综合征是特发性多中心Castleman病的一个亚型吗

2020-07-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

SLS-005（海藻糖）治疗Sanfilippo综合征：EMA持积极意见

2020-07-24

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：动态监测血液和凝血参数可更准确便捷评估COVID-19患者病情和预后

2020-07-15

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：内皮病变、凝血病与新冠肺炎患者预后

2020-07-03

科室
- - 订阅+
  - 更多科室
工具
服务